Salim Yusuf

Author PubWeight™ 10.96^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy).	J Am Coll Cardiol	2013	4.58
2	Association of handgrip strength to cardiovascular mortality in pre-diabetic and diabetic patients: a subanalysis of the ORIGIN trial.	Int J Cardiol	2014	0.93
3	Polypills: essential medicines for cardiovascular disease secondary prevention?	J Am Coll Cardiol	2014	0.91
4	Dabigatran etexilate and reduction in serum apolipoprotein B.	Heart	2015	0.83
5	Global cardiovascular research training for implementation science, health systems research, and health policy research.	J Am Coll Cardiol	2015	0.81
6	World Heart Federation Emerging Leaders Program: An Innovative Capacity Building Program to Facilitate the 25 × 25 Goal.	Glob Heart	2015	0.81
7	Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trial.	Int J Cardiol	2015	0.77
8	Reducing Premature Cardiovascular Morbidity and Mortality in People With Atherosclerotic Vascular Disease: The World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease.	Glob Heart	2015	0.77
9	Wealth and cardiovascular health: a cross-sectional study of wealth-related inequalities in the awareness, treatment and control of hypertension in high-, middle- and low-income countries.	Int J Equity Health	2016	0.75
10	Secondary CV Prevention in South America in a Community Setting: The PURE Study.	Glob Heart	2016	0.75
11	Diet and Major Renal Outcomes: A Prospective Cohort Study. The NIH-AARP Diet and Health Study.	J Ren Nutr	2016	0.75
12	Impact of a Genetic Risk Score on Myocardial Infarction Risk Across Different Ethnic Populations.	Can J Cardiol	2016	0.75